Clinical Trial Details
EORTC-40023
Back to Clinical Trials Database
Multicentre, double-blind, placebo-controlled randomised phase III study of adjuvant therapy with celecoxib in combination with chemotherapy in patients with curatively resected stage III colon cancer (PETACC-5).
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 01-Mar-2004 Date Step1 close: 02-Nov-2005 |
| Data management at EORTC | Yes |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 150 - All Groups: 1450 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00085163 |
| NCT number | NCT00085163 |
